Jun Ruan

Experience: Proven expertise in regulatory (9 years) and clinical research (9 years) with Asia Pacific exposure. Obtained 9 CTAs and MAAs licenses in China. Successfully managed 10+ multinational/China clinical trials in various therapeutic areas with a focus on project management and monitoring. Designed and developed 20+ trial protocols including BE, PK/PD, phase I, II and III for oncology drug products including molecular targeted therapy. Qualification & Skills: CSCO (China Society Clinical Oncology) Membership (2015) Licensed Pharmacist, SFDA (2001) Excellent English orally and in written. Education: M.P.H. Epidemiology and Biostatistics, Peking University (2012-2015) B.S. Pharmacy, Shenyang Pharmaceutical University (1992-1997) Presentation & Publications: 1. Ruan J, Wang ZF. Cross-sectional Study on Occupational Roles of CRA. Chinese Journal of New Drugs [J]. 2014; 23(23): 2762-2766. 2. Ruan J, Wang ZF. Cross-sectional Study on Occupational Stress of Clinical Research Associates in China. J Clin Trials [J]. 2014; 4: 167. doi:10.4172/2167-0870.1000167 Open Access: http://omicsgroup.org/journals/clinical-trials.php 3. CRA occupational stress status - A survey from 180 Chinese CRAs (oral presentation). Clinical Trial Summit 6th, Nov 5th, 2013. Beijing, China 4. Quality Control of Clinical Trials. Clinical Investigator Training Program (oral presentation). Dec 28th, 2012. Changsha, China 5. Challenges of clinical monitoring in China (moderator of panel discussion). Clinical Trial Summit 5th, Nov 15th, 2012. Beijing, China 6. Fu L, Ruan J, etc. Distritution and metabolish of gensenoside Rg3 in mice with transplanted S180 sarcoma. 6th Natural Medcine Source Acdamic Symposium. August 20th, 2004. Xi'An, China. 7. Ruan J. Zanamivir. Foreign Medicine on Synthetic Drug, Biologic Drug and Dosage Preparation [J]. 2000; 21(3): 169-170. 8. Ruan J. Abacavir sulfate. Chinese Journal of New Drugs [J]. 2000; 9(8): 578